The city of Columbus, Ohio, currently has 3 active clinical trials seeking participants for Amyotrophic Lateral Sclerosis research studies.
A Study of Ranolazine in ALS
Recruiting
The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/11/2025
Locations: The Ohio State University, Columbus, Ohio
Conditions: Amyotrophic Lateral Sclerosis
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
Recruiting
This is a multicenter, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early-stage ALS (within 2 years of ALS symptoms onset). The study comprises a core double-blind (DB) 40-week treatment period followed by an open label extension (OLE).
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
06/23/2025
Locations: The Ohio State University, Columbus, Ohio
Conditions: Amyotrophic Lateral Sclerosis (ALS)
PREVENT ALL ALS Study
Recruiting
The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is begin funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) and managed by two clinical coordinating centers (CCC) at Barrow Neurological Institute and Massachusetts General Hospital. The cl... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: Ohio State University, Columbus, Ohio
Conditions: Amyotrophic Lateral Sclerosis